Castle Biosciences, Inc. (CSTL)

USD 19.89

(0.96%)

Total Assets Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual total assets in 2023 was 477.81 Million USD , up 6.81% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly total assets in 2024 Q1 was 458.5 Million USD , down -4.04% from previous quarter.
  • Castle Biosciences, Inc. reported annual total assets of 447.32 Million USD in 2022, down -3.3% from previous year.
  • Castle Biosciences, Inc. reported annual total assets of 462.57 Million USD in 2021, up 5.29% from previous year.
  • Castle Biosciences, Inc. reported quarterly total assets of 458.5 Million USD for 2024 Q1, down -4.04% from previous quarter.
  • Castle Biosciences, Inc. reported quarterly total assets of 487.31 Million USD for 2024 Q2, up 6.28% from previous quarter.

Annual Total Assets Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Total Assets of Castle Biosciences, Inc. (2023 - 2017)

Year Total Assets Total Assets Growth
2023 477.81 Million USD 6.81%
2022 447.32 Million USD -3.3%
2021 462.57 Million USD 5.29%
2020 439.32 Million USD 266.88%
2019 119.74 Million USD 434.46%
2018 22.4 Million USD 128.15%
2017 9.82 Million USD 0.0%

Peer Total Assets Comparison of Castle Biosciences, Inc.

Name Total Assets Total Assets Difference
Aspira Women's Health Inc. 6.26 Million USD -7530.326%
bioAffinity Technologies, Inc. 8.22 Million USD -5711.689%
Intelligent Bio Solutions Inc. 13.77 Million USD -3367.71%
Standard BioTools Inc. 323.06 Million USD -47.898%
Inotiv, Inc. 856.53 Million USD 44.215%
Prenetics Global Limited 254.17 Million USD -87.988%
Neuronetics, Inc. 115.83 Million USD -312.507%
Star Equity Holdings, Inc. 86.97 Million USD -449.372%
Psychemedics Corporation 13.27 Million USD -3500.686%
RadNet, Inc. 2.88 Billion USD 83.448%
Exact Sciences Corporation 6.47 Billion USD 92.616%
IDEXX Laboratories, Inc. 3.25 Billion USD 85.343%
iSpecimen Inc. 15.81 Million USD -2920.462%
OpGen, Inc. 1.88 Million USD -25284.774%
Exagen Inc. 56.94 Million USD -739.089%
Bionano Genomics, Inc. 214.4 Million USD -122.855%
CareDx, Inc 484.61 Million USD 1.404%
Check-Cap Ltd. 25.01 Million USD -1809.945%
Twist Bioscience Corporation 776.4 Million USD 38.458%
Guardant Health, Inc. 1.78 Billion USD 73.253%
Biodesix, Inc. 99.09 Million USD -382.17%
BioNexus Gene Lab Corp. 11.39 Million USD -4091.401%
Precipio, Inc. 18.1 Million USD -2539.694%
Natera, Inc. 1.45 Billion USD 67.209%
Fulgent Genetics, Inc. 1.27 Billion USD 62.469%
Sera Prognostics, Inc. 95.44 Million USD -400.635%
23andMe Holding Co. 395.16 Million USD -20.914%
OPKO Health, Inc. 2.01 Billion USD 76.248%
Personalis, Inc. 225.09 Million USD -112.267%
Aclaris Therapeutics, Inc. 197.4 Million USD -142.046%
Applied DNA Sciences, Inc. 13.65 Million USD -3400.043%
T2 Biosystems, Inc. 34.79 Million USD -1273.138%
Neogen Corporation 4.58 Billion USD 89.577%
Myriad Genetics, Inc. 1.19 Billion USD 60.139%
ICON Public Limited Company 16.98 Billion USD 97.188%
NeoGenomics, Inc. 1.68 Billion USD 71.58%
Star Equity Holdings, Inc. 86.97 Million USD -449.372%
MDxHealth SA 129.13 Million USD -270.018%
Prenetics Global Limited 254.17 Million USD -87.988%
Illumina, Inc. 10.11 Billion USD 95.274%
DarioHealth Corp. 96.38 Million USD -395.711%
ENDRA Life Sciences Inc. 6.75 Million USD -6974.336%
Medpace Holdings, Inc. 1.65 Billion USD 71.161%
Mainz Biomed B.V. 15.4 Million USD -3000.851%
Trinity Biotech plc 59.43 Million USD -703.922%
Sotera Health Company 3.13 Billion USD 84.737%
bioAffinity Technologies, Inc. 8.22 Million USD -5711.689%